We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
TMO.MX

Price
7455.00
Stock movement up
+- (%)
Company name
Thermo Fisher Scientific Inc
Exchange
(MX
,
Currency
MXN
)
Sector
Healthcare >
Diagnostics & Research
Markedsværdi
2851.54B
Ent værdi
2895.43B
Pris/omsætning
67.34
Pris/bog
59.99
Udbytte afkast
-
Udbyttevækst
-
Vekst år
-
FCF-udbetaling
6.97%
Efterfølgende P/E
458.37
Fremtidig P/E
-
PEG
-
EPS-vekst
16.24%
1 års afkast
-28.99%
3 års afkast
-10.58%
5 års afkast
-0.98%
10 års afkast
14.06%
Senest opdateret: 2025-06-22

UDBYTTE

TMO.MX betaler ikke udbytte

VÆRDIANSÆTTELSE

Værdiansættelsesforhold

Loading...
Værdiansættelsesforhold-data
Efterfølgende P/E458.37
Pris til OCF305.04
Pris til FCF358.10
Pris til EBITDA-
EV i forhold til EBITDA-

Værdiansættelse (salg/bogført værdi)

Loading...
Værdiansættelse (salg/bogført værdi)-data
Pris til omsætning67.34
Pris til egenkapital59.99
EV i forhold til salg68.38

ØKONOMI

Pr. aktie

Loading...
Data pr. aktie
Aktuelt antal aktier382.50M
EPS (TTM)16.29
FCF pr. aktie (TTM)20.85

Resultatopgørelse

Loading...
Resultatopgørelse-data
Omsætning (TTM)42.35B
Bruttofortjeneste (TTM)17.26B
Driftsindkomst (TTM)7.47B
Nettoindkomst (TTM)6.22B
EPS (TTM)16.29
EPS (1 år frem)-

Marginer

Loading...
Marginer-data
Bruttomargin (TTM)40.76%
Driftsmargin (TTM)17.64%
Fortjenstmargin (TTM)14.69%

Balance

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
Kontanter7.07B
Nettotilgodehavender7.94B
Omsætningsaktiver i alt25.48B
Goodwill43.84B
Immaterielle aktiver15.52B
Ejendomme, anlæg og udstyr0.00
Sum aktiver98.50B
Kreditor2.55B
Kortfristet/nuværende langsigtet gæld0.00
Summen af kortfristede forpligtelser14.77B
Sum gæld50.96B
Aktionærernes egenkapital47.53B
Materielle nettoaktiver0.00

Likviditet

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
Likviditet fra driften (TTM)9.35B
Investeringsudgifter (TTM)1.39B
Fri pengestrøm (TTM)7.96B
Udbetalt udbytte (TTM)555.00M

Finansiel indkomst

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
Egenkapitalafkast13.09%
Afkast af aktiver6.32%
Afkast af investeret kapital7.99%
Kontant afkast af investeret kapital10.23%

INFORMATION OM AKTIER

Aktiediagram

Loading...
Aktiekurs-data
Åbning7455.00
Daglig høj7455.00
Daglig lav7455.00
Daglig volumen0K
Højeste gennem alle tider14014.82
1 års analytiker estimat-
Beta0.79
EPS (TTM)16.29
Udbytte pr. aktie-
Ex-div dato13 Jun 2025
Næste dato for resultatpræsentation22 Jul 2025

Nedsidepotensial

Loading...
Nedsidepotensial-data
TMO.MXS&P500
Nuværende prisfald fra top notering-46.81%-2.53%
Højeste prisfald-47.12%-56.47%
Højeste efterår dato17 Jun 20259 Mar 2009
Gennemsnitlig fald fra toppen-10.79%-11.04%
Gennemsnitlig tid til nyt højdepunkt5 days12 days
Maks. tid til nyt højdepunkt896 days1805 days
OPLYSNINGER OM VIRKSOMHEDEN
TMO.MX (Thermo Fisher Scientific Inc) company logo
Markedsværdi
2851.54B
Markedsværdi kategori
Large-cap
Beskrivelse
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar
Personale
122000
Investor relationer
-
SEC-indsendelser
Adm. direktør
Land
Mexico
By
Aktietype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
FORSTÅ FORRETNINGEN
Loading...
NYHEDER OM VIRKSOMHEDEN
Alle nyhederPressemeddelelser
Life sciences firm Waters will take on $4 billion in debt, and issue 39.2% of its shares to Becton Dickinson shareholders.
14. juli 2025
Investors need to pay close attention to TMO stock based on the movements in the options market lately.
14. juli 2025
CARLSBAD, Calif., July 14, 2025--Today, Thermo Fisher Scientific announced that the Oncomine™ Comprehensive Assay Plus* is now available on the Ion Torrent™ Genexus™ System* helping accelerate precisi...
14. juli 2025
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the 13 Best Large Cap Stocks to Buy Right Now. On July 11, Scotiabank upgraded its rating for Thermo Fisher Scientific Inc. (NYSE:TMO) from “Sector P...
13. juli 2025
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: TD ...
12. juli 2025
The global ultrasensitive molecular amplification market is experiencing robust growth, driven by advances in diagnostic technologies and rising demand for precise detection of infectious and genetic ...
11. juli 2025
WALTHAM, Mass., July 10, 2025--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.43...
10. juli 2025
SAP, NVO, TMO and FONR navigate growth and headwinds as analysts spotlight cloud momentum, obesity drugs, and innovation plays.
10. juli 2025
SAP gains on cloud strength, NVO faces obesity setbacks, and TMO leans on AI and innovation amid macro headwinds.
9. juli 2025
The year kicked off with a handful of acquisitions from top companies. Dealmaking has since slowed amid economic uncertainty but could be poised for a rebound.
9. juli 2025
Næste side